Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraureteral of Alkalinized Lidocaine as Novel Approach to Post-Ureteroscopy Pain: Double-blind Prospective Randomized Controlled Trial

NCT01450566 is registered in ClinicalTrials.gov with Queen's University as lead sponsor.

NCT NCT01450566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01450566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraureteral of Alkalinized Lidocaine as Novel Approach to Post-Ureteroscopy Pain: Double-blind Prospective Randomized Controlled Trial
Lead sponsor
Queen's University
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2011
Completion date
December 31, 2013
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal calculi, ureteral calculi